VanEck ETF Trust VanEck ... Aktie - GENZ

VanEck ETF Trust VanEck Digital Native Economy ETF (GENZ) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

35,50

( 0,04% )

Gebot

35,50

Fragen

35,65

Volumen

217

35,24 Tagesbereich 35,50

34,20 52-Wochen-Bereich 76,25

Handelsende

35,4847

Handelsbeginn

35,24

Letzte Trade

35.5

Letzter Handelszeitpunkt

15:37:00

Durchschnittliches Volumen (3 Mio.)

1.814

Finanzvolumen

US$ 7.704

VWAP

35,50

VanEck Converts Gaming ETF into GENZ ETF Targeting Digital Native Economy

As GenZ and millennials reshape the economy through digital-first behaviors, VanEck is relaunching its Gaming ETF (BJK) as the VanEck Digital...

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation -- Company Announces Four-Day Subsequent Offer Period for Remaining...

Standard & Poor's Announces Change to U.S. Index

Standard & Poor's Announces Change to U.S. Index PR Newswire NEW YORK, March 29, 2011 NEW YORK, March 29, 2011 /PRNewswire/ -- BlackRock Inc...

Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares

Genzyme Corporation (NASDAQ: GENZ) announced today that its Board of Directors unanimously recommends that Genzyme shareholders...

Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group

Genzyme Corporation (Nasdaq: GENZ) today announced that it has completed the sale of its pharmaceutical intermediates business...

Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program

Genzyme Corporation (NASDAQ: GENZ) today recognized International Rare Disease Day with the launch of a new program, the...

Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across A...

Genzyme Corporation (NASDAQ: GENZ) today announced three-year follow-up data from patients enrolled in the phase 2 clinical...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.2	-0.560224089636	35.7	35.7	34.2	2496	34.93438497	SP
4	0.78	2.2465437788	34.72	36.75	34.2	2596	35.20914353	SP
12	-40.75	-53.4426229508	76.25	76.25	34.2	1814	35.82157192	SP
26	-40.75	-53.4426229508	76.25	76.25	34.2	849	35.82157192	SP
52	-40.75	-53.4426229508	76.25	76.25	34.2	419	35.82157192	SP
156	-40.75	-53.4426229508	76.25	76.25	34.2	140	35.82157192	SP
260	-40.75	-53.4426229508	76.25	76.25	34.2	84	35.82157192	SP

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
Y232Akanda Corp	20,00 € (52,67%)	1,17k
6Q5Fathom Nickel Inc	0,0226 € (48,68%)	43,99k
JN9Spirit Blockchain Capital Inc	0,0065 € (30,00%)	38,51k
Q3JGlobal Uranium Corp	0,0466 € (25,27%)	47,65k
AMIMedondo Holding AG	0,1105 € (23,88%)	887
PU11Social Chain AG	0,0055 € (-45,00%)	10
TPG0The Platform Group SE and Co KGaA	1,495 € (-34,14%)	791,69k
3PMInfinity Metals Ltd	0,0075 € (-31,82%)	52k
0QL0Virgin Galactic Holdings Inc	3,662 € (-27,20%)	435,97k
L3O0Modern Plant Based Foods Inc	0,0402 € (-26,37%)	414
D7GNel ASA	0,2365 € (-3,07%)	3,19M
LHADeutsche Lufthansa AG	8,508 € (3,05%)	1,98M
TUI1Tui AG	7,00 € (4,07%)	1,73M
DRHDroneShield Limited	1,7655 € (4,87%)	1,61M
IJ8Itm Power	1,464 € (-2,01%)	1,41M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

VanEck ETF Trust VanEck Digital Native Economy ETF (GENZ)

VanEck ETF Trust VanEck Digital Native Economy ETF (GENZ) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

GENZ Neueste Nachrichten

VanEck Converts Gaming ETF into GENZ ETF Targeting Digital Native Economy

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation

Standard & Poor's Announces Change to U.S. Index

Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares

Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group

Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program

Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across A...

Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year

Video Available: Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right

Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right

VanEck Converts Gaming ETF into GENZ ETF Targeting Digital Native Economy

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

VanEck ETF Trust VanEck Digital Native Economy ETF (GENZ)

VanEck ETF Trust VanEck Digital Native Economy ETF (GENZ) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

GENZ Neueste Nachrichten

VanEck Converts Gaming ETF into GENZ ETF Targeting Digital Native Economy

Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation

Standard & Poor's Announces Change to U.S. Index

Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares

Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group

Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program

Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across A...

Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year

Video Available: Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right

Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right

VanEck Converts Gaming ETF into GENZ ETF Targeting Digital Native Economy

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich GRATIS und erhalten Sie:

Werbung entfernen